Coronavirus continues to wreak havoc around the world. Scientists around the world are engaged in developing vaccines to deal with this global epidemic. The trial of the coronavirus vaccine in many countries is in the final stages. Meanwhile, the World Health Organization (WHO) on Friday cautioned about the ongoing anti-viral drug Remdesivir used to treat coronavirus. The WHO said that Remdesivir should not be used for the treatment of corona patients. This is not getting any evidence of the recovery of corona infected patients.
International experts from the WHO Guideline Development Group (GDG) said, “The data present at present does not give any evidence that the Remdesivir patients are recovering from this drug. The latest guidelines say that the panel has not found any such evidence of Remdesivir, which shows that the drug has reduced the mortality rate or after its use, the patients need mechanical ventilation, etc. Remdesivir was first created for the Ebola virus, but the drug could not get much success.
Thereafter, ten drugs were also used on coronavirus patients. Some of the trials also yielded better results. This led to the use of Remdesivir drug to heal corona patients in many countries around the world. In India, it is now being used only in emergency cases and full clearance has not been received.
The WHO’s last month’s trial revealed that corona patients did not have a little or no drug effect at all. The latest guidelines of who is a powerful setback for the pharmaceutical company. The WHO’s Guideline Development Group panel said its recommendation is based on an aliens review, which includes trial data of more than 7,000 patients.
However, the US, THE EUROPEAN Union, and other countries have approved the temporary use of Remdesivir. In the initial research, the move was taken on Remdesivir after it came to help reduce recovery time in some patients.